Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2020

01-12-2020 | Diabetic Retinopathy | Research article

Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach

Authors: Jyh-Tong Hsieh, Fu-Pang Chang, An-Hang Yang, Der-Cherng Tarng, Chih-Yu Yang

Published in: BMC Nephrology | Issue 1/2020

Login to get access

Abstract

Background

Diabetic nephropathy (DN) is the most prevalent cause of renal disease in type 2 diabetic patients and is usually diagnosed clinically. A kidney biopsy is considered when non-diabetic renal disease (NDRD) is suspected, such as rapid progression in renal function impairment and severe proteinuria. Still, there is yet no consensus on the timing of kidney biopsy in type 2 diabetic patients. This study aims to identify markers that can help differentiate between DN and NDRD and guide the decision of kidney biopsy.

Methods

We retrospectively reviewed patients with type 2 diabetes who received kidney biopsy from 2008 to 2017 at Taipei Veterans General Hospital. Ophthalmologist consultation and outpatient records, diagnosis of kidney biopsy, laboratory data, and clinical characteristics were collected.

Results

This study enrolled 160 type 2 diabetic patients, among which 120 (75%) had isolated DN and 40 (25%) had NDRD ± DN (26 had isolated NDRD, and 14 had NDRD superimposed on DN). In multivariate logistic regression analysis, DM duration (odds ratio [OR]: 0.907; 95% confidence interval [CI]: 0.842–0.977; P = 0.01), diabetic retinopathy (OR: 0.196; 95% CI: 0.061–0.627; P = 0.006), and urinary RBC (OR: 1.068; 95% CI: 1.024–1.115; P = 0.002) were independent predictors of NDRD. In patients with diabetic retinopathy (n = 112, 70%), the presence of proliferative diabetic retinopathy, pan-retinal photocoagulation, and hematuria were factors predicting NDRD; and in patients without diabetic retinopathy (n = 48, 30%), short DM duration and hematuria were factors predicting NDRD.

Conclusions

Using diabetic retinopathy, DM duration, and hematuria, we developed a 3-step approach to stratify patients into three categories with the different likelihoods of having NDRD. Then different strategies could be taken accordingly. Our stepwise approach is easy to follow and may serve as an appropriate and useful tool to help clinicians in making decisions of kidney biopsy in type 2 DM patients presenting with kidney diseases.
Appendix
Available only for authorised users
Literature
1.
Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56–64.PubMedCrossRef
2.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.PubMedCrossRef
3.
Prakash J. Non-diabetic renal disease (NDRD) in patients with type 2 diabetes mellitus (type 2 DM). J Assoc Physicians India. 2013;61(3):194–9.PubMed
4.
5.
American Diabetes Association. Microvascular complications and foot care:standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1): S124–S138.
6.
Foundation NK. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850–86.CrossRef
7.
Parving HH, Gall MA, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992;41:758–62.PubMedCrossRef
8.
Anders H-J, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361–77.PubMedCrossRef
9.
Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol. 2013;8:1718–24.PubMedPubMedCentralCrossRef
10.
Fiorentino M, Bolignano D, Tesar V, Pisano A, Van Biesen W, Tripepi G, et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant. 2017;32:97–110.PubMedCrossRef
11.
Iwai T, Miyazaki M, Yamada G, Nakayama M, Yamamoto T, Satoh M, et al. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clin Exp Nephrol. 2018;22:328–36.PubMedCrossRef
12.
Tan J, Zwi LJ, Collins JF, Marshall MR, Cundy T. Presentation, pathology and prognosis of renal disease in type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5:1–9.CrossRef
13.
Lee YH, Kim KP, Kim YG, Moon JY, Jung SW, Park E, et al. Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. Medicine (Baltimore). 2017;96:1–7.
14.
Zhuo L, Ren W, Li W, Zou G, Lu J. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases. Int Urol Nephrol. 2013;45(1):173–9.PubMedCrossRef
15.
Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia. 1996;39(12):1638–45.PubMedCrossRef
16.
Jiang S, Wang Y, Zhang Z, Dai P, Yang Y, Li W. Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2018;143:288–300.PubMedCrossRef
17.
Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71:884–95.PubMedCrossRef
18.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRefPubMedPubMedCentral
19.
Liu D, Huang T, Chen N, Xu G, Zhang P, Luo Y, et al. The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study. PeerJ. 2018;6:e4522.PubMedPubMedCentralCrossRef
20.
Liu S, Guo Q, Han H, Cui P, Liu X, Miao L, et al. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol. 2016;48:1691–8.PubMedPubMedCentralCrossRef
21.
Byun JM, Lee CH, Lee SR, Moon JY, Lee SH, Lee TW, et al. Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes. Korean J Intern Med. 2013;28:565–72.PubMedPubMedCentralCrossRef
22.
Oh SW, Kim S, Na KY, Chae DW, Kim S, Jin DC, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97:418–24.PubMedCrossRef
23.
Tone A, Shikata K, Matsuda M, Usui H, Okada S, Ogawa D, et al. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Pract. 2005;69:237–42.PubMedCrossRef
24.
Klein R, Zinman B, Gardiner R, Suissa S, Donnelly SM, Sinaiko AR, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the renin-angiotensin system study. Diabetes. 2005;54(2):527–33.PubMedCrossRef
25.
KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–154.
26.
Prakash J, Lodha M, Singh SK, Vohra R, Raja R, Usha. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients. J Assoc Physicians India. 2007;55(JUNE):412–6.PubMed
27.
He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia. 2013;56:457–66.PubMedCrossRef
28.
Kritmetapak K, Anutrakulchai S, Pongchaiyakul C, Puapairoj A. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients. Clin Kidney J. 2018;11:342–7.PubMedCrossRef
29.
Dong Z, Wang Y, Qiu Q, Zhang X, Zhang L, Wu J, et al. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients. Diabetes Res Clin Pract. 2016;121:112–8.PubMedCrossRef
30.
Liu M, Chen X, Sun X, Zhou J, Zhang X, Zhu H, et al. Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic model. J Diabetes. 2014;6:519–26.PubMedCrossRef
31.
Liang S, Zhang XG, Cai GY, Zhu HY, Zhou JH, Wu J, et al. Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis. PLoS One. 2013;8:e64184.PubMedPubMedCentralCrossRef
32.
Chong YB, Keng TC, Tan LP, Ng KP, Kong WY, Wong CM, et al. Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: a single Centre review. Ren Fail. 2012;34:323–8.PubMedCrossRef
33.
Dong ZY, Wang YD, Qiu Q, Hou K, Zhang L, Wu J, et al. Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics. J Diabetes Investig. 2016;7:115–20.PubMedCrossRef
34.
Bi H, Chen N, Ling G, Yuan S, Huang G, Liu R. Nondiabetic renal disease in type 2 diabetic patients: a review of our experience in 220 cases. Ren Fail. 2011;33:26–30.PubMedCrossRef
35.
Zhou J, Chen X, Xie Y, Li J, Yamanaka N, Tong X. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases. Nephrol Dial Transplant. 2008;23:1940–5.PubMedCrossRef
36.
Akimoto T, Ito C, Saito O, Takahashi H, Takeda S, Ando Y, et al. Microscopic hematuria and diabetic glomerulosclerosis - Clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin Pract. 2008;109:119–26.CrossRef
37.
Mak SK, Gwi E, Chan KW, Wong PN, Lo KY, Lee KF, et al. Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant. 1997;12:2588–91.PubMedCrossRef
38.
O'Neill WM, Wallin JD, Walker PD. Hematuria and red cell casts in typical diabetic nephropathy. Am J Med. 1983;74(3):389–95.PubMedCrossRef
39.
Amoah E, Glickman JL, Malchoff CD, Sturgill BC, Kaiser DL, Bolton WK. Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol. 1988;8(3):204–11.PubMedCrossRef
40.
Lopes De Faria JBML, Lopes De Faria SR, Ramos OL, Pereira AB. Glomerular hematuria in diabetics. Clin Nephrol. 1988;30:117–21.PubMed
41.
Serra A, Romero R, Bayés B, Lopez D, Bonet J. Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes? Diabetes Res Clin Pract. 2002;58(2):149–53.PubMedCrossRef
42.
Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int. 1992;41(4):749–57.PubMedCrossRef
43.
Fan JZ, Wang R. Non-diabetic renal disease in patients with type 2 diabetes: a single Centre study. Intern Med J. 2018;48:451–6.PubMedCrossRef
44.
Yenigun EC, Dede F, Ozturk R, Turgut D, Koc E, Piskinpasa SV, et al. Non-diabetic renal disease in diabetes mellitus: clinical features and renal biopsy findings. Hippokratia. 2015;19:148–52.PubMedPubMedCentral
45.
Soleymanian T, Hamid G, Arefi M, Najafi I, Ganji MR, Amini M, et al. Non-diabetic renal disease with or without diabetic nephropathy in type 2 diabetes: clinical predictors and outcome. Ren Fail. 2015;37:572–5.PubMedCrossRef
46.
Sabanayagam C, Foo VHX, Ikram MK, Huang H, Lim SC, Lamoureux EL, et al. Is chronic kidney disease associated with diabetic retinopathy in Asian adults? J Diabetes. 2014;6:556–63.PubMedCrossRef
47.
Wilfred DC, Mysorekar VV, Venkataramana RS, Eshwarappa M, Subramanyan R. Nondiabetic renal disease in type 2 diabetes mellitus patients: a clinicopathological study. J Lab Physicians. 2013;5:94–9.PubMedPubMedCentralCrossRef
48.
Harada K, Akai Y, Sumida K, Yoshikawa M, Takahashi H, Yamaguchi Y, et al. Significance of renal biopsy in patients with presumed diabetic nephropathy. J Diabetes Investig. 2013;4:88–93.PubMedCrossRef
49.
Mou S, Wang Q, Liu J, Che X, Zhang M, Cao L, et al. Prevalence of non-diabetic renal disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2010;87:354–9.PubMedCrossRef
50.
Wu WP, Shu KH, Cheng CH, Chen CH, Lee WC. Proteinuria over 7 G per day predicts non-diabetic nephropathy in type 2 diabetic patients. Acta Nephrologica. 2006;20:22–7.
51.
Soni SS, Gowrishankar S, Kishan AG, Raman A. Non diabetic renal disease in type 2 diabetes mellitus. Nephrology. 2006;11:533–7.PubMedCrossRef
Metadata
Title
Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach
Authors
Jyh-Tong Hsieh
Fu-Pang Chang
An-Hang Yang
Der-Cherng Tarng
Chih-Yu Yang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2020
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-020-01794-w

Other articles of this Issue 1/2020

BMC Nephrology 1/2020 Go to the issue

Research article

High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients

Study protocol

Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial

Research article

Bundled care in acute kidney injury in critically ill patients, a before-after educational intervention study

Research article

Acute kidney injury after nephrectomy: a new nomogram to predict postoperative renal function

Correction

Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study

Research article

Low dose of flurbiprofen axetil decrease the rate of acute kidney injury after operation: a retrospective clinical data analysis of 9915 cases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits